United States of America
Tuberculosis profile
Population  2013 320 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.49 (0.48–0.5) 0.15 (0.15–0.16)
Mortality (HIV+TB only) 0.08 (0.048–0.12) 0.02 (0.01–0.04)
Prevalence  (includes HIV+TB) 13 (5.7–24) 4.1 (1.8–7.4)
Incidence  (includes HIV+TB) 11 (10–12) 3.3 (3.1–3.7)
Incidence (HIV+TB only) 0.71 (0.66–0.79) 0.22 (0.21–0.25)
Case detection, all forms (%) 86 (77–92)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 1.2 (0.98–1.6) 3.9 (1.9–7.1)
MDR-TB cases among notified pulmonary
TB cases
90 (70–110) 18 (9–32)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 5 972    
Pulmonary, clinically diagnosed 1 228    
Extrapulmonary 1 915    
       
Total new and relapse 9 115    
Previously treated, excluding relapses 457    
Total cases notified 9 572    
Among 9 110 new cases:
478 (5%) cases aged under 15 years; male:female ratio: 1.5
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 6 741 (113%) 286 (63%) 7 115
Laboratory-confirmed RR-/MDR-TB cases     108
Patients started on MDR-TB treatment     90
TB/HIV 2013 Number (%)
TB patients with known HIV status 8 360 (87)
HIV-positive TB patients 559 (7)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New cases registered in 2012 84
Previously treated cases registered in 2012 80
HIV-positive TB cases, all types, registered in 2012 75
RR-/MDR-TB cases started on second-line treatment in 2011 79
XDR-TB cases started on second-line treatment in 2011 60
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2014  
National TB programme budget (US$ millions) 135
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-07-04 Data: www.who.int/tb/data